Genfleet Therapeutics (Shanghai), Inc. Class H ( ($HK:2595) ) just unveiled an announcement. GenFleet Therapeutics has initiated the first ...

A study from the Hospital del Mar Research Institute, published in The Journal of Clinical Investigation, indicates that the high expression of the estrogen receptor is the main factor preventing the ...

The DNA inside our cells is constantly being damaged, and one of the worst kinds of damage is a double-strand break-when both sides of the DNA helix are cut at once.

A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a ...

Additionally, beyond adapting existing drug combinations, cutting-edge therapies such as bispecific antibodies and CAR T-cell ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a specific protein, RASH3D19, that is ...

LP-184 shows promising efficacy and safety in heavily pretreated advanced cancer patients, paving the way for innovative ...

Gordon Freeman, Harvard Medical School professor of medicine at Dana-Farber Cancer Institute, and Arlene Sharpe, the ...

Nanotube pathways enhance drug delivery in bladder cancer, improving hydroxycamptothecin penetration and efficacy in animal ...

New research breaks down how sunlight impacts your skin cells, sparking a chain reaction that can lead to cancer. Here's what ...

On a research end, scientists are digging more into this pathway that leads to skin cancer with hopes of creating new ...

A new nanoparticle vaccine successfully prevented several aggressive cancers in mice, including pancreatic and melanoma. The ...